Richter-Helm bring key new CMO offers to BIO-International 2015

Hamburg, Germany: – Highly respected German contract manufacturer and developer Richter-Helm will be bringing contract manufacturing services as well as co-development options to the forthcoming BIO-International Convention in Philadelphia.

Richter-Helm will once again be an exhibitor at the flagship four-day event, which opens on June 15.

In-licensing and outlicensing opportunities

The Richter-Helm team at Booth #3628 at the Pennsylvania Convention Center will be holding details of a range of new opportunities that the company’s researchers and production experts have developed. These include new potential contract development and manufacturing (CDMO) applications in microbial products as well as exciting new biosimilar products.

Richter-Helm is also seeking to identify potential new in-licensing partners for products in the field of women’s health.

Networking and partnering

“This great American event with its sophisticated networking facilities provides a peerless opportunity to meet business partners and potential new customers via one-to-one meetings,” said Richter-Helm Managing Director, Federico Pollano, who will head the convention team in Philadelphia.

“We will be exploring new business opportunities in microbial contract development and manufacturing. We are also seeking collaborators for interesting in-licensing and co-development options for microbial-derived products,” added Mr. Pollano.

The Richter-Helm team will be reaching out in particular to biotech and pharma companies with microbial derived biopharmaceuticals in their pipeline that can benefit from its sophisticated CDMO services, as well as companies with biological products for in-licensing and co-development.

About Richter-Helm

Richter-Helm is a German-based contract development and manufacturing organization (CDMO) that specializes in process development and GMP-compliant manufacture of products derived from microbial expression systems, principally bacteria and yeasts.

Richter-Helm is one of Europe’s longest established biotechnology companies, with more than 25 years of experience in the development and GMP production of recombinant proteins, plasmid DNA and microbial vaccines.

Richter-Helm offers services with highest pharmaceutical quality, confirmed by many audits of customers and regulatory authorities (FDA, EMA, ANVISA, MFDS). The services include process development and GMP manufacturing for preclinical and clinical trials as well as commercial supply.

In addition, the company has own development products in clinical trials and offers strategic partnerships based on co-development and risk-sharing models.

The company has developed its own products in the therapeutic areas of diabetes and osteoporosis, including a highly promising drug now in late-stage clinical trials. It also provides an ideal platform for its owners, Gedeon Richter and Helm AG, to develop worldwide licensing options as well as partnerships for co-development and marketing of biopharmaceutical development projects.

About BIO-International 2015

The BIO-International® Convention is a flagship conference providing life science companies with further high caliber knowledge sharing and partnering opportunities. The convention attracts some 15,500 people, from more than 65 countries worldwide.

The 2015 BIO-International Convention is a four-day event opening June 15 at the Pennsylvania Convention Center in central Philadelphia.

The BIO-International convention has been running since 2003 and consistently attracts executives from established and emerging pharma and biotech companies, along with academic researchers and private investors including venture capital and private equity and organizations developing companion diagnostics.

More information at: http://convention.bio.org